首页> 外国专利> Nucleoside aryl phosphoramidates and their use as antiviral agents for the treatment of hepatitis C virus

Nucleoside aryl phosphoramidates and their use as antiviral agents for the treatment of hepatitis C virus

机译:核苷芳基氨基磷酸酯及其作为抗病毒药治疗丙型肝炎病毒的用途

摘要

1.A compound of formula I: wherein: ar includes two or more Aromatic Rings FUSED and are selected from the group consisting of aryl and heteroaryl (C9 - 30) (C6) any such rings are optionally substituted; t is selected from the group consisting of hydrogen (- H), Fluorine (f) (N3), azido, amino (- NH2), hydroxyl (- Oh), alkyl (c1-3) (c1-3)Alkoxyl (C1 - mercapto - (3) - SH) and Alquiltio (c1-3) (C1 - 3S); V is selected from the group consisting of - ot ', Hydrogen (- H), Fluorine (F -) and chlorine (CL), where t is selected from the Group It consists of hydrogen (- H), Methyl (- CH3) (C1 - 16), alkyl (alkyl carbonyl (C1 - 16) - C (= o) - (C2), alquenil Carbonyl (- 18) alquenil (C2 - 18) - C (= o) - (C1), alkoxy carbonyl (- 10) alkyl (C1 - 10) - or - C (= o) -)Cicloalquil (C3 carbonyl (6) cicloalquil (C3 - 6) - C (= o) -), cicloalquiloxy (C3 carbonyl (6) cicloalquil (C3 - 6) - or - C (= o) -); t is selected from the group consisting of hydrogen (- H), Methyl alkyl ((CH3), C1 (16) carbonyl alkyl (C1 - 16) - C (= o) - (C2), alquenil carbonyl (18) alquenil (C2 - 18) - C (= o) -), alkyl XI (C1 - (10) carbonyl alkyl (C1 - 10) - or - C (= o) -), cicloalquil (C3 carbonyl (6) cicloalquil (C3 - 6) - C (= o) -)Cicloalquiloxy (C3 carbonyl (6) cicloalquil (C3 - 6) - or - C (= o) -); n is 0 OR 1.Where is when n = 1, X is o, and when n is 0, there is a double Bond between the 3 and the 4 position and Position x is selected from the group consisting of H, o, F, CL, BR, I, alkyl (C1 - 6) and nr5r6, where each in R5 and R6 is independently selected from H and alkyl (C1 - 6); Z is sele Ccionado group consisting of H, o, F, CL, BR, I, alkyl (C1 - 6) and nr5r6,Where each of R5 and R6 is independently selected from H and alkyl (C1 - 6); and is selected from the group consisting of H, o, F, CL, BR, I, alkyl (6 alquinilo (C1, C2) - 8) and nr5r6, where each) R6 is independently selected from H and alkyl (C1 - 6); Q is Selection The ado group consisting of o, s and cr7r8,...
机译:1.式I的化合物:其中:ar包括两个或多个FUSED芳环,并且选自芳基和杂芳基(C9-30)(C6),任何这样的环任选地被取代; t选自氢(-H),氟(f)(N3),叠氮基,氨基(-NH2),羟基(-Oh),烷基(c1-3)(c1-3)烷氧基(C1 -巯基-(3)-SH)和Alquiltio(c1-3)(C1-3S); V选自-ot',氢(-H),氟(F-)和氯(CL),其中t选自下组:它由氢(-H),甲基(-CH3)组成(C1-16),烷基(烷基羰基(C1-16)-C(= o)-(C2),alquenil羰基(-18)Alquenil(C2-18)-C(= o)-(C1),烷氧基羰基(-10)烷基(C1-10)-或-C(= o)-)邻氯基(C3羰基(6)环氯基(C3-6)-C(= o)-),环氯基氧基(C3羰基(6) cicloalquil(C3-6)-或-C(= o)-); t选自氢(-H),甲基烷基((CH3),C1(16)羰基烷基(C1-16)-C(= o)-(C2),Alquenil羰基(18)Alquenil( C2-18)-C(= o)-),烷基XI(C1-(10)羰基烷基(C1-10)-或-C(= o)-),环氯喹(C3羰基(6)环氯吡咯(C3- 6)-C(= o)-)环烷氧基(C3羰基(6)cicloalquil(C3-6)-或-C(= o)-); n为0或1.当n = 1时,X为o,当n为0时,在3和4位置之间存在一个双键,并且位置x选自H,o,F ,CL,BR,I,烷基(C1-6)和nr5r6,其中R5和R6中的每一个独立地选自H和烷基(C1-6); Z是由H,o,F,CL,BR,I,烷基(C1-6)和nr5r6组成的硒代硅氧烷基团,其中R5和R6各自独立地选自H和烷基(C1-6);且选自H,o,F,CL,BR,I,烷基(6烷基喹啉(C1,C2)-8)和nr5r6,其中每个)R6独立地选自H和烷基(C1-6 ); Q是Selection由o,s和cr7r8,...组成的ado组。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号